中国民族药的专利保护分析

发布时间：2018-05-25 05:17

本文选题：医药知识产权 + 民族药　；参考：《中国实验方剂学杂志》2011年22期

【摘要】：目的:研究国内6家代表性民族药企业及其部分主打产品专利的申请量、类别、授权率等,分析民族药的知识产权保护现状,为我国民族药产业发展提出建议。方法:运用中外专利搜索引擎Soopat数据库,检索6家代表性民族药企业(奇正藏药集团有限公司、内蒙古蒙药股份有限公司、新疆维吾尔药业有限责任公司、贵州益佰医药有限责任公司、云南傣药有限公司、云南白药集团股份有限公司)及其主打产品(奇正藏药的奇正消痛贴膏、贵州益佰的镇痛活络酊、云南白药的云南白药气雾剂)的专利申请状况,数据截止专利申请公开或公告日为2011年3月10日。结果:民族药企业专利申请参差不齐,近年来专利申请量增加迟缓;部分主打产品专利质量高,发明专利比率大;民族药产业发展离不开知识产权尤其是专利的保护。结论:知识产权保护特别是专利制度在民族药发展中占有举足轻重的作用,民族药生产企业需加强专利申请意识,充分运用专利保护制度,注重专利战略和专利结构类型,抓住"十二五"知识产权政策优势,努力发展成为产业链,增强经济实力,为民族药走向世界做出贡献。
[Abstract]:Objective: to study the patent application amount, category and authorization rate of 6 representative national pharmaceutical enterprises and their main products in China, analyze the current situation of intellectual property protection of national medicine, and put forward some suggestions for the development of national pharmaceutical industry in China. Methods: by using the Soopat database of Chinese and foreign patent search engines, six representative national pharmaceutical enterprises (Qizheng Tibetan Medicine Group, Inner Mongolia Mongolian Pharmaceutical Co., Ltd., Xinjiang Uygur Pharmaceutical Co., Ltd.) were searched. Guizhou Yibai Pharmaceutical Co., Ltd., Yunnan Dai Medicine Co., Ltd., Yunnan Baiyao Group Co., Ltd.) and its main products (Qizheng Xiaotong paste of Qizheng Tibetan Medicine, analgesic and Huoluo Tincture of Guizhou Yibai, Yunnan Baiyao (Yunnan Baiyao aerosol) status of patent applications, data as of the date of publication of patent applications or public notice is March 10, 2011. Results: the patent application of national pharmaceutical enterprises was uneven, the amount of patent application increased slowly in recent years, the patent quality of some main products was high, the ratio of invention patent was large, and the development of national pharmaceutical industry could not be separated from intellectual property rights, especially the protection of patent. Conclusion: the intellectual property protection, especially the patent system, plays an important role in the development of national medicine. The enterprises producing national medicine should strengthen the consciousness of patent application, make full use of the patent protection system, and pay attention to the patent strategy and the type of patent structure. Seize the advantage of intellectual property policy in the 12th Five-Year Plan, strive to develop into an industrial chain, strengthen economic strength, and contribute to national medicine to the world.
【作者单位】：新乡医学院药学院;湖南康普医药研究院;康普药业股份有限公司;
【基金】：湖南省知识产权局软课题(HNR2010208)
【分类号】：R29

【二级参考文献】